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Modern	research	of	novel	antitumor	drugs	 is	 fo-
cused	on	the	study	of	molecular	mechanisms	of	their	
cytostatic	activity	and	the	prevention	of	toxic	effects.	
One	of	such	substances,	mechanisms	of	which	action	
need	a	thorough	research	is	hydrobromide	5-(5’,6’-
benzocoumaroyl-3’)-methylaminouracil	(BCU).	As	we	
have	shown	earlier,	BCU	possesses	potent	anticancer	
activity	[1–3].	The	structure	and	properties	of	BCU	al-
low	to	predict	its	ability	to	cause	degradation	of	DNA	
in	tumor	cells.	That’s	why	the	aim	of	the	present	work	
was	to	study	the	effect	of	BCU	administration	on	the	
stability	of	nuclear	DNA	of	tumor	cells	in vivo.	
The	research	was	performed	on	3-month	old	female	
white	inbred	rats	(n	=	150)	weighting	110	to	130	g.	Guerin	
carcinoma	(Gc)	was	used	as	experimental	tumor	model.	
The	strain	of	the	tumor	was	kindly	granted	by	R.E.	Ka-
vetsky	 Institute	of	Experimental	Pathology,	Oncology	
and	Radiobiology,	National	Academy	of	Sciences	of	
Ukraine.	All	animal	procedures	were	performed	ac-
cording	to	the	rules	of	local	ethic	committee.	Animal’s	
euthanasia	was	made	under	light	ether	anesthesia.
Gc	cells	were	 routinely	 transplanted	subcutane-
ously	 in	hip	area	of	each	animal.	The	animals	were	
divided	into	the	groups:	group	І	(experimental)	–	rats	
that	received	per os	BCU	at	the	dose	of	6	mg/kg	body	
weight	every	day	from	7-th	to	21st	days	after	Gc	trans-
plantation;	group	 ІІ	 (control)	—	Gc-bearing	animals	
without	treatment.	
At	the	7-th,14-th	and	21-st	days	after	Gc	transplan-
tation	(responding	to	latent,	logarithmic	and	exponen-
tial	 stages	of	 tumor	growth),	 the	samples	of	 tumor	
tissue	were	 isolated,	 fixed	 in	10%	formalin,	and	 the	
slides	were	routinely	prepared,	stained	by	hematoxy-
lin	and	eosin	[4],	and	examined	by	light	microscopy	
(magnification	100X).	
Nuclear	 fraction	of	Gc	cells	was	 isolated	by	 the	
method	[4].	Acidic	and	alkaline	DNases	activity	was	
determined	by	 the	degree	of	chromatin	hydrolysis.	
The	degree	of	chromatin	hydrolysis	was	calculated	by	
the	number	of	polydeoxyribonucleotides	(PDN)	of	the	
acid-soluble	fraction,	received	after	the	incubation	of	
the	nuclear	fraction	in	corresponding	buffers	for	10,	20	
and	30	min	at	37	°С	and	expressed	in	percentage	of	the	
total	DNA	in	incubation	mixture	[3].	The	significance	
of	the	differences	between	the	data	was	evaluated	by	
regression	analysis	[5].
DNA	was	isolated	by	the	standard	phenol	:	chlo-
roform	:	isopropanol	extraction	method	and	analyzed	
by	electrophoresis	in	1%	agarose	gel	[6].	Gels	were	
scanned	with	 the	help	of	 “GelDoc	2000”	apparatus	
and	analyzed	using	the	program	“Quantity	One”	(Bio-
Rad,	USA).
Complexes	of	BCU	with	high	molecular	DNA	iso-
lated	from	Gc	cells	at	the	7th	day	were	received	in vitro	
by	mixing	equimolecular	solutions	of	BCU	and	DNA	
(concentration	of	10‾4	mol/l)	 in	0.01	mol/l	NaCl;	 the	
solution	was	kept	at	room	temperature	and	constant	
stirring	for	2	h.	The	ability	of	BCU	to	interact	with	the	
DNA	was	evaluated	by	UV-spectrophotometry	at	the	
wave	length	of	220–340	nm	[7].	The	capacity	of	the	
BCU-DNA	complex	was	determined	graphically	by	
alteration	of	ΔD	value	dependent	on	the	concentration	
of	the	added	ligand.	
The	differences	between	 the	 indexess	were	as-
sessed	using	Student’s	t-criterium	[5].
The	study	of	BCU-treated	Gc-bearing	animals	has	
shown	that	 in	Gc	cells	nuclei	the	 increase	of	DNase	
activity	and	DNA	 fragmentation	could	be	observed.	
BCU	administration	caused	the	increase	of	acidic	and	
alkaline	DNase	activities	in	tumor	nuclei	already	from	
the	beginning	of	BCU	administration	(Fig.	1).	However,	
its	administration	did	not	change	the	general	tendency	
of	 increase	of	DNase	 ІІ	activity	 in	 tumor	cells	of	 the	
control	group	(Fig.	1,	а),	which	is	caused	by	intensi-
fied	proliferation	of	tumor	cells	and	active	role	of	the	
enzyme	 in	replication	and	reparation	processes	[3].	
In	contrast	to	that,	positive	correcting	effect	of	BCU	
administration	was	manifested	by	the	increase	of	al-
kaline	DNase	activity	during	the	logarithmic	period	of	
tumor	growth,	which	is	characterized	by	the	decrease	
of	DNase	I	activity	in	the	control	group	(Fig.	1,	b).	
Thus,	BCU	action	on	DNase	activity	resulted	in	the	
simultaneous	 increase	of	acidic	and	alkaline	DNase	
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activities,	pointing	on	 the	absence	of	 its	specificity	
toward	mentioned	enzymes.	Possibly,	BCU,	being	an	
antimetabolite	[1],	can	interact	with	DNA	causing	the	
formation	of	DNA	complexes	or	single-	and	double	
strand	breaks	etc.
fig. 1. PDN	content	in	the	nuclear	fraction	of	Gc	cells	of	experi-
mental	animals	and	acidic	(a)	and	alkaline	(b) DNases	activity.	
Notes:	1,	2	—	14,	21	days	after	Gc	transplantation	accordingly;	
*р <	0.05	compared	with	14th	day;	**р <	0.05	in	compared	with	
control	group.
Also,	it	has	been	revealed	that	BCU	administration	
leads	to	DNA	fragmentation	in	Gc	cells	and	appearance	
of	high-molecular	DNA	fragments	(10–50	kb)	(Fig.	2),	
typical	for	apoptosis	[8–9].	One	could	not	exclude	that	
BCU	as	some	other	anticancer	drugs	 [10]	may	act	
through	in	the	inhibition	of	topoisomerases.	
fig. 2. Electrophoregrams	of	the	fragmented	nuclear	DNA	of	
Guerin	carcinoma	of	control	(lane	1)	and	experimental	(lane	2)	
groups.	M	—	marker	preparation	Gene	RulerTM
Gc	tissue	slides	examined	by	light	microscopy	have	
demonstrated	 the	changes	 in	 the	architectonics	of	
tumor	tissue	(Fig.	3).	In	the	tumor	cells	from	Gc	iso-
lated	at	the	14-th	day	of	the	experiment	of	Gc-treated	
animals,	chromatin	condensation	and	nuclei	picnosis	
could	be	seen	(Fig.	3,	b).	Morphology	characteristic	
to	tumor	cells	was	observed	on	the	slides	of	Gc	tissue	
of	the	control	group:	disproportional	large-size	nuclei	
could	be	viewed	occupying	all	the	inner	contents	of	the	
cell,	with	diffuse	chromatin	(Fig.	3,	а).
fig. 3. Guerin	carcinoma	tissue	slides:	control	(a)	and	experi-
mental	(b)	groups
To	 test	 the	assumption	on	a	possible	direct	 in-
teraction	of	BCU	with	nuclear	DNA,	we	performed	a	
spectroscopic	in vitro	examination	of	mixtures	of	DNA	
and	BCU.	The	analysis	of	UV-absorption	spectra	al-
lows	asserting	 the	existence	of	 interaction	between	
BCU	and	DNA	molecule	 in vitro	by	 the	appearance	
of	isobestic	point	[11]	on	the	diagrams	of	absorption	
spectra	(Fig.	4).	The	existence	of	one	isobestic	point	
shows	single	type	of	interaction	[11].	Taking	into	ac-
count	that	BCU	has	a	flat	heterocyclic	structure	and	
a	non-electrophilic	composition	[1],	the	centers	of	its	
binding	are	DNA	bases	[12,	13].	For	verification	of	this	
suggestion,	differential	spectra	of	the	DNA	and	BCU	
solutions	were	studied	(Fig.	5).	In	our	experiment	the	
differential	curves	are	located	under	the	abscissa	and	
have	a	sinusoidal	shape	allowing	to	state	that	BCU	in-
teracts	with	the	bases	by	intercalation,	but	not	ruining	
DNA	double-helical	structure	[14].	Also,	the	BCU-DNA	
complexes	possess	a	significant	stability	and	poorly	
dissociate	(data	not	shown).	
fig. 4. UV-spectra	of	BCU	solutions	 (•),	Guerin	carcinoma	
nuclear	DNA	(◊)	and	BCU-DNA	equimolar	mixture	(∎)
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fig. 5. Differential	absorption	spectra	of	DNA	solutions	in	the	
presence	of	BCU	
So	we	have	 shown	 that	 administration	of	BCU	
causes	chromatin	condensation	and	appearance	of	
high-molecular	DNA	fragments	in	tumor	cell	nuclei.
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ВОЗМОЖНЫЙ МЕХАНИЗМ ПРОТИВООПУХОЛЕВОЙ 
АКТИВНОСТИ 5‑(5’,6’‑БЕНЗОКУМАРoИЛ‑3’)‑
МЕТИЛАМИНОУРАцИЛА in vivo
Цель: проаналаизировать возможные механизмы противоопухолевой активности гидробромида 5-(5’,6’-бензокумариoл-3’)-
метиламиноурацила (BCU) in vivo. Методы: BCU вводили в дозе 6 мг/кг в течение 7 дней крысам с трансплантированной 
карциномой Герена (КГ). Взаимодействие BCU с ДНК, выделенной из клеток КГ, анализировали методами электрофореза 
и спектрофотометрии. Результаты: установлено, что введение BCU приводит к конденсации хроматина, пикнозу ядер, 
повышению ДНКазной активности и появлению высокомолекулярных фрагментов ДНК в клетках КГ. Выводы: BCU 
может прямо взаимодействовать с молекулами ДНК с образованием стабильных комплексов.
Ключевые слова: гидробромид 5-(5’,6’-бензокумарил-3’)-метиламиноурацила, карцинома Герена, ДНК.
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